>AT2G41820.1 | leucine-rich repeat transmembrane protein kinase putative
MTFWCMSILLIVGFLSKSELCEAQLSDEATLVAINRELGVPGWSSNGTDYCTWVGLKCGV
NNSFVEMLDLSGLQLRGNVTLISDLRSLKHLDLSGNNFNGRIPTSFGNLSELEFLDLSLN
RFVGAIPVEFGKLRGLRAFNISNNLLVGEIPDELKVLERLEEFQVSGNGLNGSIPHWVGN
LSSLRVFTAYENDLVGEIPNGLGLVSELELLNLHSNQLEGKIPKGIFEKGKLKVLVLTQN
RLTGELPEAVGICSGLSSIRIGNNELVGVIPRTIGNISGLTYFEADKNNLSGEIVAEFSK
CSNLTLLNLAANGFAGTIPTELGQLINLQELILSGNSLFGEIPKSFLGSGNLNKLDLSNN
RLNGTIPKELCSMPRLQYLLLDQNSIRGDIPHEIGNCVKLLQLQLGRNYLTGTIPPEIGR
MRNLQIALNLSFNHLHGSLPPELGKLDKLVSLDVSNNLLTGSIPPLLKGMMSLIEVNFSN
NLLNGPVPVFVPFQKSPNSSFLGNKELCGAPLSSSCGYSEDLDHLRYNHRVSYRIVLAVI
GSGVAVFVSVTVVVLLFMMREKQEKAAAKNVDVEENVEDEQPAIIAGNVFLENLKQGIDL
DAVVKATMKESNKLSTGTFSSVYKAVMPSGMIVSVKKLKSMDRAISHHQNKMIRELERLS
KLCHDHLVRPIGFVIYEDVALLLHQHLPNGNLTQLIHESTKKPEYQPDWPMRLSIAVGAA
EGLAFLHQVAIIHLDVSSSNVLLDSGYKAVLGEIEISKLLDPSRGTASISSVAGSFGYIP
PEYAYTMQVTAPGNVYSYGVVLLEILTSRAPVEEEFGEGVDLVKWVHGASARGETPEQIL
DAKLSTVSFAWRREMLAALKVALLCTDITPAKRPKMKKVVEMLQEVKQIK*
>AT3G57430.1 | pentatricopeptide (PPR) repeat-containing protein
MSCPLAFTFSLPSIFPFPSQLLPFSRHKHPYLLRATPTSATEDVASAVSGAPSIFISQSR
SPEWWIDLLRSKVRSNLLREAVLTYVDMIVLGIKPDNYAFPALLKAVADLQDMELGKQIH
AHVYKFGYGVDSVTVANTLVNLYRKCGDFGAVYKVFDRISERNQVSWNSLISSLCSFEKW
EMALEAFRCMLDENVEPSSFTLVSVVTACSNLPMPEGLMMGKQVHAYGLRKGELNSFIIN
TLVAMYGKLGKLASSKVLLGSFGGRDLVTWNTVLSSLCQNEQLLEALEYLREMVLEGVEP
DEFTISSVLPACSHLEMLRTGKELHAYALKNGSLDENSFVGSALVDMYCNCKQVLSGRRV
FDGMFDRKIGLWNAMIAGYSQNEHDKEALLLFIGMEESAGLLANSTTMAGVVPACVRSGA
FSRKEAIHGFVVKRGLDRDRFVQNTLMDMYSRLGKIDIAMRIFGKMEDRDLVTWNTMITG
YVFSEHHEDALLLLHKMQNLERKVSKGASRVSLKPNSITLMTILPSCAALSALAKGKEIH
AYAIKNNLATDVAVGSALVDMYAKCGCLQMSRKVFDQIPQKNVITWNVIIMAYGMHGNGQ
EAIDLLRMMMVQGVKPNEVTFISVFAACSHSGMVDEGLRIFYVMKPDYGVEPSSDHYACV
VDLLGRAGRIKEAYQLMNMMPRDFNKAGAWSSLLGASRIHNNLEIGEIAAQNLIQLEPNV
ASHYVLLANIYSSAGLWDKATEVRRNMKEQGVRKEPGCSWIEHGDEVHKFVAGDSSHPQS
EKLSGYLETLWERMRKEGYVPDTSCVLHNVEEDEKEILLCGHSEKLAIAFGILNTSPGTI
IRVAKNLRVCNDCHLATKFISKIVDREIILRDVRRFHRFKNGTCSCGDYW*
>AT1G21730.1 | kinesin-related protein (MKRP1)
MSATRSQRSSTISPARPRRSPATIPMKRPETPSSSHFSASPVTSSSPLLRSSPSPSTSSA
AASSTAVASTKLKENITVTIRFRPLSPREVNNGDEIAWYADGDYTIRNEYNPSLCYGFDR
VFGPPTTTRRVYDIAAQQVVSGAMSGINGTVFAYGVTSSGKTHTMHGEQRSPGIIPLAVK
DVFSIIQETPEREFLLRVSYLEIYNEVINDLLDPTGQNLRIREDSQGTYVEGIKDEVVLS
PAHALSLIASGEEHRHVGSNNVNLFSSRSHTMFTLTIESSPHGKGDDGEDVSLSQLHLID
LAGSESSKTEITGQRRKEGSSINKSLLTLGTVISKLTDTKAAHIPYRDSKLTRLLQSTLS
GHGRVSLICTITPASSTSEETHNTLKFAQRCKHVEIKASRNKIMDEKSLIKKYQKEISCL
QEELTQLRHGNQDDLADRKLQVKLQSRLEDDEEAKAALMGRIQRLTKLILVSTKSSLQAA
SVKPDHIWRQAFGEDELAYLPDRRRENMADDGAVSTVSEHLKEPRDGNSSLDEMTKDRRK
NKTRGMLGWLKLKKSDGVAGTLPTDGNQSQASGSPSSSSKYTQTKTTRRENAAAIKSIPE
KTVAGDLFSATVGPEDSSPTGTTIADQMDLLHEQTKILVGEVALRTSSLNRLSEQAARNP
EDFHIRDQIQKLEDEISEKKDQIRVLEQQIIEIFGMTPYASDSLGMPQVLSKLTMQLNEK
IFEHEIKSADNRILQEQLQMTKSENAEMQETIILLRQQLDSLAERQSTQQIAGDESSGKN
IHNRNGEESEIYSGAGTPTSVMSLNRVFAQEETKEIYNETALNSQALEIENLKKEKMRLI
EEKDELGKLNKKLTEEASYAKELASAAAVELQNLAEEVTRLCNENAKLSR*
>AT4G04370.1 | pentatricopeptide (PPR) repeat-containing protein
MIRTSSVLNSTKYFNSHINHLSSHGDHKQVLSTFSSMLANKLLPDTFTFPSLLKACASLQ
RLSFGLSIHQQVLVNGFSSDFYISSSLVNLYAKFGLLAHARKVFEEMRERDVVHWTAMIG
CYSRAGIVGEACSLVNEMRFQGIKPGPVTLLEMLSGVLEITQLQCLHDFAVIYGFDCDIA
VMNSMLNLYCKCDHVGDAKDLFDQMEQRDMVSWNTMISGYASVGNMSEILKLLYRMRGDG
LRPDQQTFGASLSVSGTMCDLEMGRMLHCQIVKTGFDVDMHLKTALITMYLKCGKEEASY
RVLETIPNKDVVCWTVMISGLMRLGRAEKALIVFSEMLQSGSDLSSEAIASVVASCAQLG
SFDLGASVHGYVLRHGYTLDTPALNSLITMYAKCGHLDKSLVIFERMNERDLVSWNAIIS
GYAQNVDLCKALLLFEEMKFKTVQQVDSFTVVSLLQACSSAGALPVGKLIHCIVIRSFIR
PCSLVDTALVDMYSKCGYLEAAQRCFDSISWKDVVSWGILIAGYGFHGKGDIALEIYSEF
LHSGMEPNHVIFLAVLSSCSHNGMVQQGLKIFSSMVRDFGVEPNHEHLACVVDLLCRAKR
IEDAFKFYKENFTRPSIDVLGIILDACRANGKTEVEDIICEDMIELKPGDAGHYVKLGHS
FAAMKRWDDVSESWNQMRSLGLKKLPGWSKIEMNGKTTTFFMNHTSHSDDTVSLLKLLSR
EMMQFGSNN*
>AT4G18750.1 | DOT4 (DEFECTIVELY ORGANIZED TRIBUTARIES 4)
MAMLVTNLSSSSFCFFSSPHLQNQKEIRSGVRVRKYVIFNRASLRTVSDCVDSITTFDRS
VTDANTQLRRFCESGNLENAVKLLCVSGKWDIDPRTLCSVLQLCADSKSLKDGKEVDNFI
RGNGFVIDSNLGSKLSLMYTNCGDLKEASRVFDEVKIEKALFWNILMNELAKSGDFSGSI
GLFKKMMSSGVEMDSYTFSCVSKSFSSLRSVHGGEQLHGFILKSGFGERNSVGNSLVAFY
LKNQRVDSARKVFDEMTERDVISWNSIINGYVSNGLAEKGLSVFVQMLVSGIEIDLATIV
SVFAGCADSRLISLGRAVHSIGVKACFSREDRFCNTLLDMYSKCGDLDSAKAVFREMSDR
SVVSYTSMIAGYAREGLAGEAVKLFEEMEEEGISPDVYTVTAVLNCCARYRLLDEGKRVH
EWIKENDLGFDIFVSNALMDMYAKCGSMQEAELVFSEMRVKDIISWNTIIGGYSKNCYAN
EALSLFNLLLEEKRFSPDERTVACVLPACASLSAFDKGREIHGYIMRNGYFSDRHVANSL
VDMYAKCGALLLAHMLFDDIASKDLVSWTVMIAGYGMHGFGKEAIALFNQMRQAGIEADE
ISFVSLLYACSHSGLVDEGWRFFNIMRHECKIEPTVEHYACIVDMLARTGDLIKAYRFIE
NMPIPPDATIWGALLCGCRIHHDVKLAEKVAEKVFELEPENTGYYVLMANIYAEAEKWEQ
VKRLRKRIGQRGLRKNPGCSWIEIKGRVNIFVAGDSSNPETENIEAFLRKVRARMIEEGY
SPLTKYALIDAEEMEKEEALCGHSEKLAMALGIISSGHGKIIRVTKNLRVCGDCHEMAKF
MSKLTRREIVLRDSNRFHQFKDGHCSCRGFW*
>AT4G21300.1 | pentatricopeptide (PPR) repeat-containing protein
MSISSVAKRFAPAIAPYKKSLPLRNSSRFLEETIPRRLSLLLQACSNPNLLRQGKQVHAF
LIVNSISGDSYTDERILGMYAMCGSFSDCGKMFYRLDLRRSSIRPWNSIISSFVRNGLLN
QALAFYFKMLCFGVSPDVSTFPCLVKACVALKNFKGIDFLSDTVSSLGMDCNEFVASSLI
KAYLEYGKIDVPSKLFDRVLQKDCVIWNVMLNGYAKCGALDSVIKGFSVMRMDQISPNAV
TFDCVLSVCASKLLIDLGVQLHGLVVVSGVDFEGSIKNSLLSMYSKCGRFDDASKLFRMM
SRADTVTWNCMISGYVQSGLMEESLTFFYEMISSGVLPDAITFSSLLPSVSKFENLEYCK
QIHCYIMRHSISLDIFLTSALIDAYFKCRGVSMAQNIFSQCNSVDVVVFTAMISGYLHNG
LYIDSLEMFRWLVKVKISPNEITLVSILPVIGILLALKLGRELHGFIIKKGFDNRCNIGC
AVIDMYAKCGRMNLAYEIFERLSKRDIVSWNSMITRCAQSDNPSAAIDIFRQMGVSGICY
DCVSISAALSACANLPSESFGKAIHGFMIKHSLASDVYSESTLIDMYAKCGNLKAAMNVF
KTMKEKNIVSWNSIIAACGNHGKLKDSLCLFHEMVEKSGIRPDQITFLEIISSCCHVGDV
DEGVRFFRSMTEDYGIQPQQEHYACVVDLFGRAGRLTEAYETVKSMPFPPDAGVWGTLLG
ACRLHKNVELAEVASSKLMDLDPSNSGYYVLISNAHANAREWESVTKVRSLMKEREVQKI
PGYSWIEINKRTHLFVSGDVNHPESSHIYSLLNSLLGELRLEGYIPQPYLPLHPESSRKV
YPVSRFIEKEMRDPDKV*
>AT5G52850.1 | pentatricopeptide (PPR) repeat-containing protein
MTSKVVAAAASAFLSRTNELGNLQKSCIRILSFCESNSSRIGLHIHCPVIKFGLLENLDL
CNNLLSLYLKTDGIWNARKLFDEMSHRTVFAWTVMISAFTKSQEFASALSLFEEMMASGT
HPNEFTFSSVVRSCAGLRDISYGGRVHGSVIKTGFEGNSVVGSSLSDLYSKCGQFKEACE
LFSSLQNADTISWTMMISSLVGARKWREALQFYSEMVKAGVPPNEFTFVKLLGASSFLGL
EFGKTIHSNIIVRGIPLNVVLKTSLVDFYSQFSKMEDAVRVLNSSGEQDVFLWTSVVSGF
VRNLRAKEAVGTFLEMRSLGLQPNNFTYSAILSLCSAVRSLDFGKQIHSQTIKVGFEDST
DVGNALVDMYMKCSASEVEASRVFGAMVSPNVVSWTTLILGLVDHGFVQDCFGLLMEMVK
REVEPNVVTLSGVLRACSKLRHVRRVLEIHAYLLRRHVDGEMVVGNSLVDAYASSRKVDY
AWNVIRSMKRRDNITYTSLVTRFNELGKHEMALSVINYMYGDGIRMDQLSLPGFISASAN
LGALETGKHLHCYSVKSGFSGAASVLNSLVDMYSKCGSLEDAKKVFEEIATPDVVSWNGL
VSGLASNGFISSALSAFEEMRMKETEPDSVTFLILLSACSNGRLTDLGLEYFQVMKKIYN
IEPQVEHYVHLVGILGRAGRLEEATGVVETMHLKPNAMIFKTLLRACRYRGNLSLGEDMA
NKGLALAPSDPALYILLADLYDESGKPELAQKTRNLMTEKRLSKKLGKSTVEVQGKVHSF
VSEDVTRVDKTNGIYAEIESIKEEIKRFGSPYRGNENASFHSAKQAVVYGFIYASPEAPV
HVVKNKILCKDCHEFVSILTRLVDKKITVRDGNQVHIFKNGECSCKREETSFV*
>AT3G53360.1 | pentatricopeptide (PPR) repeat-containing protein
MATMLRLGARVSVSNSQILATSSVVSTIKTEELMNDHINSLCKSNFYREALEAFDFAQKN
SSFKIRLRTYISLICACSSSRSLAQGRKIHDHILNSNCKYDTILNNHILSMYGKCGSLRD
AREVFDFMPERNLVSYTSVITGYSQNGQGAEAIRLYLKMLQEDLVPDQFAFGSIIKACAS
SSDVGLGKQLHAQVIKLESSSHLIAQNALIAMYVRFNQMSDASRVFYGIPMKDLISWSSI
IAGFSQLGFEFEALSHLKEMLSFGVFHPNEYIFGSSLKACSSLLRPDYGSQIHGLCIKSE
LAGNAIAGCSLCDMYARCGFLNSARRVFDQIERPDTASWNVIIAGLANNGYADEAVSVFS
QMRSSGFIPDAISLRSLLCAQTKPMALSQGMQIHSYIIKWGFLADLTVCNSLLTMYTFCS
DLYCCFNLFEDFRNNADSVSWNTILTACLQHEQPVEMLRLFKLMLVSECEPDHITMGNLL
RGCVEISSLKLGSQVHCYSLKTGLAPEQFIKNGLIDMYAKCGSLGQARRIFDSMDNRDVV
SWSTLIVGYAQSGFGEEALILFKEMKSAGIEPNHVTFVGVLTACSHVGLVEEGLKLYATM
QTEHGISPTKEHCSCVVDLLARAGRLNEAERFIDEMKLEPDVVVWKTLLSACKTQGNVHL
AQKAAENILKIDPFNSTAHVLLCSMHASSGNWENAALLRSSMKKHDVKKIPGQSWIEIED
KIHIFFAEDIFHPERDDIYTVLHNIWSQMLDECNPQHKKRLQFIHETG*
>AT1G74600.1 | pentatricopeptide (PPR) repeat-containing protein
MNCLANESLNSLKISPFSTSRLLSSVTNFRNQLSFSSKDSSSSSAPFNPFRFFNDQSNSR
LCNLRTTKILQAHLLRRYLLPFDVFLTKSLLSWYSNSGSMADAAKLFDTIPQPDVVSCNI
MISGYKQHRLFEESLRFFSKMHFLGFEANEISYGSVISACSALQAPLFSELVCCHTIKMG
YFFYEVVESALIDVFSKNLRFEDAYKVFRDSLSANVYCWNTIIAGALRNQNYGAVFDLFH
EMCVGFQKPDSYTYSSVLAACASLEKLRFGKVVQARVIKCGAEDVFVCTAIVDLYAKCGH
MAEAMEVFSRIPNPSVVSWTVMLSGYTKSNDAFSALEIFKEMRHSGVEINNCTVTSVISA
CGRPSMVCEASQVHAWVFKSGFYLDSSVAAALISMYSKSGDIDLSEQVFEDLDDIQRQNI
VNVMITSFSQSKKPGKAIRLFTRMLQEGLRTDEFSVCSLLSVLDCLNLGKQVHGYTLKSG
LVLDLTVGSSLFTLYSKCGSLEESYKLFQGIPFKDNACWASMISGFNEYGYLREAIGLFS
EMLDDGTSPDESTLAAVLTVCSSHPSLPRGKEIHGYTLRAGIDKGMDLGSALVNMYSKCG
SLKLARQVYDRLPELDPVSCSSLISGYSQHGLIQDGFLLFRDMVMSGFTMDSFAISSILK
AAALSDESSLGAQVHAYITKIGLCTEPSVGSSLLTMYSKFGSIDDCCKAFSQINGPDLIA
WTALIASYAQHGKANEALQVYNLMKEKGFKPDKVTFVGVLSACSHGGLVEESYFHLNSMV
KDYGIEPENRHYVCMVDALGRSGRLREAESFINNMHIKPDALVWGTLLAACKIHGEVELG
KVAAKKAIELEPSDAGAYISLSNILAEVGEWDEVEETRKLMKGTGVQKEPGWSSV*
>AT2G32680.1 | AtRLP23 (Receptor Like Protein 23) kinase/ protein binding
MSKALLHLHFLSLFLLCCVCHSSIFTLNFHFTGIVACRPHQIQAFTKFTNEFDTRGCNNS
DTFNGVWCDNSTGAVAVLQLRKCLSGTLKSNSSLFGFHQLRYVDLQNNNLTSSSLPSGFG
NLKRLEGLFLSSNGFLGQVPSSFSNLTMLAQLDLSYNKLTGSFPLVRGLRKLIVLDLSYN
HFSGTLNPNSSLFELHQLRYLNLAFNNFSSSLPSKFGNLHRLENLILSSNGFSGQVPSTI
SNLTRLTKLYLDQNKLTSSFPLVQNLTNLYELDLSYNKFFGVIPSSLLTLPFLAHLALRE
NNLAGSVEVSNSSTSSRLEIMYLGSNHFEGQILEPISKLINLKHLDLSFLNTSYPIDLKL
FSSLKSLRSLDLSGNSISSASLSSDSYIPLTLEMLTLRHCDINEFPNILKTLKELVYIDI
SNNRMKGKIPEWLWSLPLLQSVTLGNNYFTGFQGSAEILVNSSVLLLYLDSNNFEGALPD
LPLSIKGFGVASNSFTSEIPLSICNRSSLAAIDLSYNNFTGPIPPCLRNLELVYLRNNNL
EGSIPDALCDGASLRTLDVSHNRLTGKLPRSFVNCSSLKFLSVINNRIEDTFPFWLKALP
NLQVLTLRSNRFYGPISPPHQGPLGFPELRIFEISDNKFTGSLPPNYFVNWKASSRTMNQ
DGGLYMVYEEKLFDEGGYGYTDALDLQYKGLHMEQAKALTSYAAIDFSGNRLEGQIPESI
GLLKALIAVNISNNAFTGHIPLSMANLENLESLDMSRNQLSGTIPNGLGSISFLAYINVS
HNQLTGEIPQGTQITGQSKSSFEGNAGLCGLPLKESCFGTGAPPMYHQKQEDKEEEEEEE
EEEEEVLNGRAVAIGYGSGLLLGLAIAQVIASYKPEWLVKIIGLNKRRKR*
>AT4G39952.1 | pentatricopeptide (PPR) repeat-containing protein
MLRRLLKPNLVVTLRKLSSSSASYVDRHISVILCDQSLSLESLRKHNALIITGGLSENIF
VASKLISSYASYGKPNLSSRVFHLVTRRDIFLWNSIIKAHFSNGDYARSLCFFFSMLLSG
QSPDHFTAPMVVSACAELLWFHVGTFVHGLVLKHGGFDRNTAVGASFVYFYSKCGFLQDA
CLVFDEMPDRDVVAWTAIISGHVQNGESEGGLGYLCKMHSAGSDVDKPNPRTLECGFQAC
SNLGALKEGRCLHGFAVKNGLASSKFVQSSMFSFYSKSGNPSEAYLSFRELGDEDMFSWT
SIIASLARSGDMEESFDMFWEMQNKGMHPDGVVISCLINELGKMMLVPQGKAFHGTVCNS
LLSMYCKFELLSVAEKLFCRISEEGNKEAWNTMLKGYGAVLLGKSLHCYVVKTSLDLTIS
VVNSLIDLYGKMGDLTVAWRMFCEADTNVITWNAMIASYVHCEQSEKAIALFDRMVSENF
KPSSITLVTLLMACVNTGSLERGQMIHRYITETEHEMNLSLSAALIDMYAKCGHLEKSRE
LFDAGNQKDAVCWNVMISGYGMHGDVESAIALFDQMEESDVKPTGPTFLALLSACTHAGL
VEQGKKLFLKMHQYDVKPNLKHYSCLVDLLSRSGNLEEAESTVMSMPFSPDGVIWGTLLS
SCMTHGEFEMGIRMAERAVASDPQNDGYYIMLANMYSAAGKWEEAERAREMMRESGVGKR
AGHSVV*
>AT1G62950.1 | leucine-rich repeat transmembrane protein kinase putative
MQIGKLIWVIMFIFVHIIITSSRSFSDSIITEREILLQFKDNINDDPYNSLASWVSNADL
CNSFNGVSCNQEGFVEKIVLWNTSLAGTLTPALSGLTSLRVLTLFGNRITGNLPLDYLKL
QTLWKINVSSNALSGLVPEFIGDLPNLRFLDLSKNAFFGEIPNSLFKFCYKTKFVSLSHN
NLSGSIPESIVNCNNLIGFDFSYNGITGLLPRICDIPVLEFVSVRRNLLSGDVFEEISKC
KRLSHVDIGSNSFDGVASFEVIGFKNLTYFNVSGNRFRGEIGEIVDCSESLEFLDASSNE
LTGNVPSGITGCKSLKLLDLESNRLNGSVPVGMGKMEKLSVIRLGDNFIDGKLPLELGNL
EYLQVLNLHNLNLVGEIPEDLSNCRLLLELDVSGNGLEGEIPKNLLNLTNLEILDLHRNR
ISGNIPPNLGSLSRIQFLDLSENLLSGPIPSSLENLKRLTHFNVSYNNLSGIIPKIQASG
ASSFSNNPFLCGDPLETPCNALRTGSRSRKTKALSTSVIIVIIAAAAILVGICLVLVLNL
RARKRRKKREEEIVTFDTTTPTQASTESGNGGVTFGKLVLFSKSLPSKYEDWEAGTKALL
DKDNIIGIGSIGAVYRASFEGGVSIAVKKLETLGRIRNQEEFEQEIGRLGSLSHPNLASF
QGYYFSSTMQLILSEFVTNGSLYDNLHPRVSHRTSSSSSSHGNTELNWHRRFQIAVGTAK
ALSFLHNDCKPAILHLNVKSTNILLDERYEAKLSDYGLEKFLPVLNSSGLTKFHNAVGYI
APELAQSLRVSDKCDVYSYGVVLLELVTGRKPVESPSENEVVILRDHVRNLLETGSASDC
FDRRLRGFEENELIQVMKLGLICTTENPLKRPSIAEVVQVLELIRNGMES*
>AT1G51860.1 | leucine-rich repeat protein kinase putative
MKSLHWFLHLLIIAFTVLRSVEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSDVDYID
SGLVGKINDAYKTQFQQQVWAVRSFPVGQRNCYNVNLTANNKYLIRGTFVYGNYDGLNQF
PSFDLHIGPNKWSSVKILGVTNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLN
NESYLTQSGSLMLFARVYFPSSSSSFIRYDEDIHDRVWNSFTDDETVWISTDLPIDTSNS
YDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREFNITYNG
GLRWFSYLRPPNLSISTIFNPRAVSSSNGIFNFTFAMTGNSTLPPLLNALEIYTVVDILQ
LETNKDEVSAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYPDSEGSRIISLNLNG
SELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNLTAIPDS
LQQRVNSKSLTLILGENLTLTPKKESKKVPMVAIAASVAGVFALLVILAIFFVIKRKNVK
AHKSPGPPPLVTPGIVKSETRSSNPSIITRERKITYPEVLKMTNNFERVLGKGGFGTVYH
GNLDGAEVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMA
NGDLRENMSGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCRPPMVHRDVKTTNILLNERC
GAKLADFGLSRSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVT
NQPVIDKTRERPHINDWVGFMLTKGDIKSIVDPKLMGDYDTNGAWKIVELALACVNPSSN
RRPTMAHVVMELNDCVALENARRQGSEEMYSMGSVDYSLSSTSDFAPGAR*
>AT3G25020.1 | AtRLP42 (Receptor Like Protein 42) protein binding
MSKSLLRLTFLLLLLLSCVSPSSFFTFNNPAEGPGACGPHQIQAFTQFKNEFDTRACNHS
DPWNGVWCDNSTGAVTMLQLRACLSGTLKPNSSLFQFHHLRSLLLPHNNFTSSSISSKFG
MLNNLEVLSLSSSGFLAQVPFSFSNLSMLSALDLSKNELTGSLSFVRNLRKLRVLDVSYN
HFSGILNPNSSLFELHHLIYLNLRYNNFTSSSLPYEFGNLNKLEVLDVSSNSFFGQVPPT
ISNLTQLTELYLPLNDFTGSLPLVQNLTKLSILHLFGNHFSGTIPSSLFTMPFLSSIYLN
KNNLSGSIEVPNSSSSSRLEHLYLGKNHLGKILEPIAKLVNLKELDLSFLNTSHPIDLSL
FSSLKSLLLLDLSGDWISKASLTLDSYIPSTLEVLRLEHCDISEFPNVFKTLHNLEYIAL
SNNRISGKFPEWLWSLPRLSSVFITDNLLTGFEGSSEVLVNSSVQILSLDTNSLEGALPH
LPLSINYFSAIDNRFGGDIPLSICNRSSLDVLDLSYNNFSGQIPPCLSNLLYLKLRKNNL
EGSIPDKYYVDTPLRSFDVGYNRLTGKLPRSLINCSALQFLSVDHNGIKDTFPFYLKALP
KLQVLLLSSNEFYGPLSPPNQGPLGFPELRILEIAGNKLTGSLPPDFFVNWKASSHTMNE
DLGLYMVYSKVIFGNYHLTYYETIDLRYKGLSMEQENVLTSSATIDLSGNRLEGEIPESL
GLLKALIALNLSNNAFTGHIPLSLANLKKIESLDLSSNQLSGTIPNGLGTLSFLAYMNVS
HNQLNGEIPQGTQITGQPKSSFEGNAGLCGFPLQESCFGTNAPPAQKPKEEEEAEEDEQE
LNWKAVAIGYGVGVLLGLAIAQLIASYKPEWLVCLVKSRNPLRSFFGFEY*